PL3720428T3 - Kompozycja oftalmiczna do podawania miejscowego zawierająca kwas dobezylowy do leczenia chorób tylnego odcinka oka - Google Patents

Kompozycja oftalmiczna do podawania miejscowego zawierająca kwas dobezylowy do leczenia chorób tylnego odcinka oka

Info

Publication number
PL3720428T3
PL3720428T3 PL18811023.3T PL18811023T PL3720428T3 PL 3720428 T3 PL3720428 T3 PL 3720428T3 PL 18811023 T PL18811023 T PL 18811023T PL 3720428 T3 PL3720428 T3 PL 3720428T3
Authority
PL
Poland
Prior art keywords
eye
treating diseases
topical composition
posterior segment
ophthalmic topical
Prior art date
Application number
PL18811023.3T
Other languages
English (en)
Inventor
Xavier CAPDEVILA NORTES
Javier SANAGUSTÍN AQUILUÉ
Maria Isabel DELGADO GAÑÁN
Original Assignee
Laboratorios Salvat, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Salvat, S.A. filed Critical Laboratorios Salvat, S.A.
Publication of PL3720428T3 publication Critical patent/PL3720428T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL18811023.3T 2017-12-04 2018-11-29 Kompozycja oftalmiczna do podawania miejscowego zawierająca kwas dobezylowy do leczenia chorób tylnego odcinka oka PL3720428T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382832 2017-12-04
PCT/EP2018/082999 WO2019110416A1 (en) 2017-12-04 2018-11-29 Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye

Publications (1)

Publication Number Publication Date
PL3720428T3 true PL3720428T3 (pl) 2023-05-08

Family

ID=60673756

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18811023.3T PL3720428T3 (pl) 2017-12-04 2018-11-29 Kompozycja oftalmiczna do podawania miejscowego zawierająca kwas dobezylowy do leczenia chorób tylnego odcinka oka

Country Status (24)

Country Link
US (1) US20200390729A1 (pl)
EP (1) EP3720428B1 (pl)
JP (1) JP2021505554A (pl)
KR (1) KR102756155B1 (pl)
CN (1) CN111542316A (pl)
AU (1) AU2018378981B2 (pl)
BR (1) BR112020011160A2 (pl)
CA (1) CA3083835A1 (pl)
CL (1) CL2020001426A1 (pl)
DK (1) DK3720428T3 (pl)
ES (1) ES2941036T3 (pl)
FI (1) FI3720428T3 (pl)
HR (1) HRP20230319T1 (pl)
HU (1) HUE061852T2 (pl)
MA (1) MA50991B1 (pl)
MX (1) MX2020005809A (pl)
MY (1) MY205498A (pl)
PH (1) PH12020550722A1 (pl)
PL (1) PL3720428T3 (pl)
PT (1) PT3720428T (pl)
SG (1) SG11202004940VA (pl)
SI (1) SI3720428T1 (pl)
WO (1) WO2019110416A1 (pl)
ZA (1) ZA202003944B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202300017430A1 (it) * 2023-08-22 2025-02-22 Service Biotech srl Soluzione oftalmica in forma di collirio contenente una isoforma umana ricombinante di manganese superossido dismutasi (rmnsod) per la cura di patologie dell’occhio
CN117257963B (zh) * 2023-11-02 2024-07-16 广州准优生物科技有限公司 含脐带间充质干细胞外泌体的眼用药剂及其制备方法和用途
CN117643573B (zh) * 2024-01-29 2024-05-03 天津医科大学眼科医院 一种可递送药物至眼后节的纳米滴眼液及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
US9198886B2 (en) * 2006-08-16 2015-12-01 Pedro Cuevas Sánchez Use of 2,5-dihydroxybenzene for the treatment of ocular diseases
US20140309400A1 (en) * 2011-11-30 2014-10-16 Xigen Inflammation Ltd. Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Dry Eye Syndrome
ES2632012T3 (es) * 2012-02-02 2017-09-07 Invesfovea S.L. Uso del ácido 2,5-dihidroxibenceno sulfonato para el tratamiento de la degeneración macular relacionada con la edad
JP6395611B2 (ja) * 2012-03-05 2018-09-26 ウェイン・ステート・ユニバーシティー チャネルロドプシン−2(Chop2)の変異の同定および使用法
NZ724395A (en) * 2012-04-24 2018-03-23 Thrombogenics Nv Anti-pdgf-c antibodies
EP2875811A1 (en) * 2013-11-26 2015-05-27 Luis Antonio Outeirino Miguez Use of dobesilate for treating ocular haemorrhages

Also Published As

Publication number Publication date
EP3720428A1 (en) 2020-10-14
CL2020001426A1 (es) 2020-11-06
PH12020550722A1 (en) 2021-02-15
HRP20230319T1 (hr) 2023-05-12
SI3720428T1 (sl) 2023-05-31
JP2021505554A (ja) 2021-02-18
EP3720428B1 (en) 2023-01-11
KR20200096569A (ko) 2020-08-12
CN111542316A (zh) 2020-08-14
BR112020011160A2 (pt) 2020-11-17
MY205498A (en) 2024-10-23
HUE061852T2 (hu) 2023-08-28
AU2018378981A1 (en) 2020-07-16
PT3720428T (pt) 2023-04-03
WO2019110416A1 (en) 2019-06-13
DK3720428T3 (da) 2023-03-20
SG11202004940VA (en) 2020-06-29
MX2020005809A (es) 2020-08-20
FI3720428T3 (fi) 2023-03-30
US20200390729A1 (en) 2020-12-17
AU2018378981B2 (en) 2024-10-24
KR102756155B1 (ko) 2025-01-20
ZA202003944B (en) 2022-12-21
MA50991B1 (fr) 2023-03-31
MA50991A (fr) 2020-10-14
ES2941036T3 (es) 2023-05-16
CA3083835A1 (en) 2019-06-13

Similar Documents

Publication Publication Date Title
IL277333A (en) Methods for treating eye diseases
PL3399962T3 (pl) Kompozycja okulistyczna do leczenia choroby suchego oka
EP3177732A4 (en) Compositions and methods for the treatment of ophthalmic diseases and conditions
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
EP3096617A4 (en) Compositions and methods for treating ocular diseases
EP3351219A4 (en) MATERIAL FOR THE OPTICAL TREATMENT OF OCULAR DISEASES
IL268357A (en) Photoreceptor cells for the treatment of retinal diseases
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
PL3493823T4 (pl) Składnik na bazie postbiotyki do leczenia zapalenia oka
EP3193867A4 (en) Ocular formulations for drug-delivery and protection of the anterior segment of the eye
ZA202003944B (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
ZA202002075B (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
IL269698B (en) Methods for preventing or treating eye diseases
EP3265103A4 (en) Compositions and methods for treating ocular diseases
PT3407879T (pt) Gabapentina oftálmica para o tratamento de úlceras da córnea
SMT202100070T1 (it) Complesso e composizioni per il trattamento di affezioni oculari e cutanee
IL289436A (en) Methods for treating eye diseases
IL282898A (en) Ophthalmic compounds and methods for treating skin and eye diseases
EP3129054A4 (en) Methods and compositions for the treatment of ocular diseases and disorders
HK40033459A (en) Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
HK40036198A (en) Methods for treating ocular diseases
HK40019910A (en) Methods and compositions for treating allergic ocular diseases
HK40021761A (en) Methods of preventing or treating ophthalmic diseases
IT201700099156A1 (it) Composizione oftalmica nanoparticellare per il trattamento di disturbi o patologie oculari
HK40033754A (en) Pharmaceutical compositions for the treatment of ophthalmic conditions